FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016237455> ?p ?o ?g. }

• W3016237455 endingPage "258" @default.
• W3016237455 startingPage "249" @default.
• W3016237455 abstract "Background: Diabetes is a chronic metabolic disorder affecting the central nervous system. A growing body of evidence has depicted that high glucose level leads to the activation of the transient receptor potential melastatin 2 (TRPM2) channels. However, there are no studies targeting TRPM2 channels in diabetes-induced cognitive decline using a pharmacological approach. Objective: The present study intended to investigate the effects of 2-aminoethoxydiphenyl borate (2-APB), a TRPM2 inhibitor, in diabetes-induced cognitive impairment. Methods: Streptozotocin (STZ, 50 mg/kg, i.p.) was used to induce diabetes in rats. Animals were randomly divided into the treatment group, model group and age-matched control and pre se group. 2-APB treatment was given for three weeks to the animals. After 10 days of behavioural treatment, parameters were performed. Animals were sacrificed at 10th week of diabetic induction and the hippocampus and cortex were isolated. After that, protein and mRNA expression study was performed in the hippocampus. Acetylcholinesterase (AchE) activity was done in the cortex. Results: : Our study showed the 10th week diabetic animals developed cognitive impairment, which was evident from the behavioural parameters. Diabetic animals depicted an increase in the TRPM2 mRNA and protein expression in the hippocampus as well as increased AchE activity in the cortex. However, memory associated proteins were down-regulated, namely Ca2+/calmodulin-dependent protein kinase II (CaMKII-Thr286), glycogen synthase kinase 3 beta (GSK-3β-Ser9), cAMP response element-binding protein (CREB-Ser133), and postsynaptic density protein 95 (PSD-95). Gene expression of parvalbumin, calsequestrin and brain-derived neurotrophic factor (BDNF) were down-regulated while mRNA level of calcineurin A/ protein phosphatase 3 catalytic subunit alpha (PPP3CA) was upregulated in the hippocampus of diabetic animals. A three-week treatment with 2-APB significantly ameliorated the alteration in behavioural cognitive parameters in diabetic rats. Moreover, 2-APB also down-regulated the expression of TRPM2 mRNA and protein in the hippocampus as well as AchE activity in the cortex of diabetic animals as compared to diabetic animals. Moreover, the 2-APB treatment also upregulated the CaMKII (Thr-286), GSK-3β (Ser9), CREB (Ser133), and PSD-95 expression and mRNA levels of parvalbumin, calsequestrin, and BDNF while mRNA level of calcineurin A was down-regulated in the hippocampus of diabetic animals. Conclusion: : This study confirms the ameliorative effect of TRPM2 channel inhibitor in the diabetes- induced cognitive deficits. Inhibition of TRPM2 channels reduced the calcium associated downstream signaling and showed a neuroprotective effect of TRPM2 channels in diabetesinduced cognitive impairment." @default.
• W3016237455 created "2020-04-17" @default.
• W3016237455 creator A5037109166 @default.
• W3016237455 creator A5039538410 @default.
• W3016237455 creator A5041030221 @default.
• W3016237455 date "2020-09-29" @default.
• W3016237455 modified "2023-10-01" @default.
• W3016237455 title "Pharmacological Inhibition of Transient Receptor Potential Melastatin 2 (TRPM2) Channels Attenuates Diabetes-induced Cognitive Deficits in Rats: A Mechanistic Study" @default.
• W3016237455 cites W1534752717 @default.
• W3016237455 cites W1838560231 @default.
• W3016237455 cites W1964260585 @default.
• W3016237455 cites W1971048984 @default.
• W3016237455 cites W1977182919 @default.
• W3016237455 cites W1981486828 @default.
• W3016237455 cites W1982749330 @default.
• W3016237455 cites W1991878687 @default.
• W3016237455 cites W1996462430 @default.
• W3016237455 cites W1998802978 @default.
• W3016237455 cites W2016352369 @default.
• W3016237455 cites W2036284058 @default.
• W3016237455 cites W2056102057 @default.
• W3016237455 cites W2072662467 @default.
• W3016237455 cites W2088231371 @default.
• W3016237455 cites W2092660763 @default.
• W3016237455 cites W2092926605 @default.
• W3016237455 cites W2102732075 @default.
• W3016237455 cites W2108658118 @default.
• W3016237455 cites W2148574879 @default.
• W3016237455 cites W2178843014 @default.
• W3016237455 cites W2310524135 @default.
• W3016237455 cites W2326306398 @default.
• W3016237455 cites W2420657483 @default.
• W3016237455 cites W2480735346 @default.
• W3016237455 cites W2520123270 @default.
• W3016237455 cites W2531250512 @default.
• W3016237455 cites W2551071132 @default.
• W3016237455 cites W2563900680 @default.
• W3016237455 cites W26979087 @default.
• W3016237455 cites W2760891487 @default.
• W3016237455 cites W2791956573 @default.
• W3016237455 cites W2810020941 @default.
• W3016237455 cites W2883601824 @default.
• W3016237455 cites W2884668426 @default.
• W3016237455 cites W2900468207 @default.
• W3016237455 cites W2906771164 @default.
• W3016237455 cites W2944613538 @default.
• W3016237455 cites W2946289473 @default.
• W3016237455 cites W2975457683 @default.
• W3016237455 cites W2986009335 @default.
• W3016237455 cites W2987856547 @default.
• W3016237455 cites W2997511875 @default.
• W3016237455 cites W3003746996 @default.
• W3016237455 cites W326128418 @default.
• W3016237455 cites W4211240576 @default.
• W3016237455 doi "https://doi.org/10.2174/1567202617666200415142211" @default.
• W3016237455 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32294037" @default.
• W3016237455 hasPublicationYear "2020" @default.
• W3016237455 type Work @default.
• W3016237455 sameAs 3016237455 @default.
• W3016237455 citedByCount "17" @default.
• W3016237455 countsByYear W30162374552020 @default.
• W3016237455 countsByYear W30162374552021 @default.
• W3016237455 countsByYear W30162374552022 @default.
• W3016237455 countsByYear W30162374552023 @default.
• W3016237455 crossrefType "journal-article" @default.
• W3016237455 hasAuthorship W3016237455A5037109166 @default.
• W3016237455 hasAuthorship W3016237455A5039538410 @default.
• W3016237455 hasAuthorship W3016237455A5041030221 @default.
• W3016237455 hasConcept C104317684 @default.
• W3016237455 hasConcept C126322002 @default.
• W3016237455 hasConcept C134018914 @default.
• W3016237455 hasConcept C151495721 @default.
• W3016237455 hasConcept C155164980 @default.
• W3016237455 hasConcept C15744967 @default.
• W3016237455 hasConcept C160539049 @default.
• W3016237455 hasConcept C1629964 @default.
• W3016237455 hasConcept C169760540 @default.
• W3016237455 hasConcept C170493617 @default.
• W3016237455 hasConcept C184235292 @default.
• W3016237455 hasConcept C185592680 @default.
• W3016237455 hasConcept C2778790584 @default.
• W3016237455 hasConcept C2779178840 @default.
• W3016237455 hasConcept C2779280383 @default.
• W3016237455 hasConcept C2781161787 @default.
• W3016237455 hasConcept C55493867 @default.
• W3016237455 hasConcept C555293320 @default.
• W3016237455 hasConcept C71924100 @default.
• W3016237455 hasConcept C86339819 @default.
• W3016237455 hasConcept C97029542 @default.
• W3016237455 hasConceptScore W3016237455C104317684 @default.
• W3016237455 hasConceptScore W3016237455C126322002 @default.
• W3016237455 hasConceptScore W3016237455C134018914 @default.
• W3016237455 hasConceptScore W3016237455C151495721 @default.
• W3016237455 hasConceptScore W3016237455C155164980 @default.
• W3016237455 hasConceptScore W3016237455C15744967 @default.
• W3016237455 hasConceptScore W3016237455C160539049 @default.
• W3016237455 hasConceptScore W3016237455C1629964 @default.
• W3016237455 hasConceptScore W3016237455C169760540 @default.

• next